Author:
Chen Yu,Jin Jianhao,Zhu Li,Zhang Yuxia,Wei Changlin,Yang Qihang,Yao Liang
Funder
Shanghai Municipal Key Clinical Specialty
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Huang C, Zhang S, Huang D, Hua W. Current understanding and treatment recommendations for atrial fibrillation-2018. Chin J Cardiac Pacing Electrophysiol. 2018;32:315–68.
2. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120:1501–17.
3. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305–16.
4. Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35:501–7.
5. Winkle RA. HPSD ablation for AF high-power short-duration RF ablation for atrial fibrillation: a review. J Cardiovasc Electrophysiol. 2021;32:2813–23.